The best method to obtain tissue for the diagnosis of pancreatic carcinoma is:

Correct Answer: B. Transgastric FNAC guided by endoscopic ultrasound

Endoscopic ultrasound-guided fine-needle aspiration cytology (EUS-FNAC) is the gold standard for pancreatic tissue diagnosis because it combines real-time ultrasound visualization with direct endoscopic access. The transgastric approach allows the endoscope to be positioned within 2–3 cm of the pancreatic head and body, enabling high-resolution imaging and precise needle placement under direct visualization. This technique achieves diagnostic accuracy of 85–95% with minimal morbidity. The needle passes through the gastric wall directly into the lesion, avoiding peritoneal contamination and reducing infection risk. EUS-FNAC is particularly superior for small lesions (<3 cm) that may be missed on CT or MRI. In Indian practice, this is the preferred first-line method at tertiary centers for suspected pancreatic malignancy, as it provides cytological diagnosis with low complication rates (pancreatitis <1%, bleeding <0.5%), allows tissue for immunohistochemistry and molecular testing, and can be performed as an outpatient procedure. The transgastric route specifically avoids the need for percutaneous approaches that risk peritoneal seeding in malignancy.

Why the other options are wrong

A. Percutaneous transperitoneal biopsy — This is wrong because percutaneous biopsy carries a significant risk of peritoneal seeding and tumor spillage in pancreatic malignancy, potentially upstaging the cancer and compromising surgical resectability. It also has higher morbidity (pancreatitis, bleeding, infection) and lower diagnostic accuracy (~70%) compared to EUS-FNAC. Percutaneous approaches are reserved only when EUS is contraindicated or non-diagnostic. C. MRI – guided biopsy — This is wrong because MRI guidance lacks real-time visualization and requires needle repositioning based on imaging intervals, making it technically difficult and time-consuming for pancreatic lesions. MRI-guided biopsy is rarely used for pancreatic diagnosis in clinical practice; it is primarily reserved for liver or other solid organ biopsies. The pancreas is a small, mobile organ that moves with respiration, making MRI guidance impractical and less accurate than EUS. D. Laparoscopic – guided biopsy — This is wrong because laparoscopic biopsy is an invasive surgical procedure requiring general anesthesia and carries higher morbidity than EUS-FNAC. It is reserved for staging and tissue diagnosis only when EUS has failed or when simultaneous staging laparoscopy is planned for resectable tumors. It is not a first-line diagnostic method and exposes the patient to unnecessary operative risk when a minimally invasive alternative exists.

High-Yield Facts

Mnemonics

EUS-FNAC Advantage: BEST Biopsy with Endoscopy Safely Transgastric — Real-time visualization, minimal morbidity, no peritoneal seeding, outpatient procedure. Why NOT Percutaneous: SPILL Seeding risk, Peritoneal contamination, Increased morbidity, Lower accuracy, Less preferred in malignancy.

NBE Trap

NBE may pair "percutaneous biopsy" with "direct access" to lure students into choosing it as the most direct route, overlooking the critical risk of peritoneal seeding in pancreatic malignancy. The trap conflates "direct access" with "safe access."

Clinical Pearl

In Indian tertiary centers, EUS-FNAC has become the standard outpatient diagnostic tool for suspected pancreatic malignancy, allowing same-day tissue diagnosis without operative risk. A patient with jaundice and a pancreatic head mass can be diagnosed and staged within 48 hours using EUS-FNAC, enabling rapid surgical planning for resectable cases.

_Reference: Bailey & Love Ch. 65 (Pancreatic Surgery); Harrison Ch. 307 (Pancreatic Cancer)_